Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer Via MiR-1270 Suppression

Overview

Journal Mol Ther Nucleic Acids

Publisher Cell Press

Date 2019 Sep 4

PMID 31479922

Citations 111

Authors

Zhao Zhao

Mei Ji

Qianqing Wang

Nannan He

Yue Li

Affiliations

Soon will be listed here.

Abstract

The aim of this study is to explore the roles of circular RNA (circRNA) Cdr1as on cisplatin resistance in ovarian cancer and explore the underlying mechanisms. We investigated the expression of circRNAs in five paired cisplatin-sensitive and cisplatin-resistant tissues of ovarian cancer by microarray analysis. The quantitative real-time PCR analysis was to investigate the expression pattern of Cdr1as in cisplatin-resistant ovarian cancer patient tissues and cell lines. Then, the effects of Cdr1as on cisplatin resistance, cell proliferation, and apoptosis were assessed in ovarian cancer cells. In this study, Cdr1as was observed to be downregulated in cisplatin-resistant patient tissues and cell lines. Overexpression of Cdr1as inhibited cell proliferation and promoted the cisplatin-induced cell apoptosis in ovarian cancer cells. Then we demonstrated that repressed Cdr1as promoted the miR-1270 expression, and miR-1270 could bind to the predicted binding site of Cdr1as. Furthermore, we found that miR-1270 displayed its role via modulating the Suppressor of Cancer Cell Invasion (SCAI) expression. Importantly, we demonstrated that Cdr1as was downregulated in serum exosomes from cisplatin-resistant patients. In summary, our study demonstrated that Cdr1as sensitizes ovarian cancer to cisplatin by regulating the miR-1270/SCAI signaling pathway.

Citing Articles

Emerging roles of exosomes in diagnosis, prognosis, and therapeutic potential in ovarian cancer: a comprehensive review.

Tuscharoenporn T, Apaijai N, Charoenkwan K, Chattipakorn N, Chattipakorn S Cancer Gene Ther. 2025; 32(2):149-164.

PMID: 39843770 DOI: 10.1038/s41417-025-00871-2.

Circular RNA CDR1as/ciRS-7- a novel biomarker in solid tumors.

Zhang Y, Xiong C, Jiang Z, Wang X, Ji J, Pan Y Front Oncol. 2024; 14:1468363.

PMID: 39678511 PMC: 11638042. DOI: 10.3389/fonc.2024.1468363.

Metformin regulates the proliferation and motility of melanoma cells by modulating the LINC00094/miR-1270 axis.

Tsai K, Liao J, Tseng H Cancer Cell Int. 2024; 24(1):384.

PMID: 39563323 PMC: 11575040. DOI: 10.1186/s12935-024-03545-5.

Circ-VPS13C enhances cisplatin resistance in ovarian cancer via modulating the miR-106b-5p/YWHAZ axis.

Yao H, Liu D, Gao F, Li Q, Liu S Arch Med Sci. 2024; 20(4):1249-1267.

PMID: 39439709 PMC: 11493060. DOI: 10.5114/aoms/133038.

Role of circRNAs in regulating cell death in cancer: a comprehensive review.

Saadh M, Ehymayed H, Alazzawi T, Fahdil A, Athab Z, Yarmukhamedov B Cell Biochem Biophys. 2024; 83(1):109-133.

PMID: 39243349 DOI: 10.1007/s12013-024-01492-6.

References

Ashwal-Fluss R, Meyer M, Pamudurti N, Ivanov A, Bartok O, Hanan M . circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014; 56(1):55-66. DOI: 10.1016/j.molcel.2014.08.019. View

Starke S, Jost I, Rossbach O, Schneider T, Schreiner S, Hung L . Exon circularization requires canonical splice signals. Cell Rep. 2014; 10(1):103-11. DOI: 10.1016/j.celrep.2014.12.002. View

Hansen T, Kjems J, Damgaard C . Circular RNA and miR-7 in cancer. Cancer Res. 2013; 73(18):5609-12. DOI: 10.1158/0008-5472.CAN-13-1568. View

Xu H, Guo S, Li W, Yu P . The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells. Sci Rep. 2015; 5:12453. PMC: 4515639. DOI: 10.1038/srep12453. View

Waldmann A, Eisemann N, Katalinic A . Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends. Geburtshilfe Frauenheilkd. 2014; 73(2):123-129. PMC: 3859169. DOI: 10.1055/s-0032-1328266. View

Thakur B, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B . Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014; 24(6):766-9. PMC: 4042169. DOI: 10.1038/cr.2014.44. View

Yu L, Gong X, Sun L, Zhou Q, Lu B, Zhu L . The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression. PLoS One. 2016; 11(7):e0158347. PMC: 4938625. DOI: 10.1371/journal.pone.0158347. View

Vargas-Hernandez V, Moreno-Eutimio M, Acosta-Altamirano G, Vargas-Aguilar V . Management of recurrent epithelial ovarian cancer. Gland Surg. 2014; 3(3):198-202. PMC: 4139130. DOI: 10.3978/j.issn.2227-684X.2013.10.01. View

Vaughan S, Coward J, Bast Jr R, Berchuck A, Berek J, Brenton J . Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer. 2011; 11(10):719-25. PMC: 3380637. DOI: 10.1038/nrc3144. View

10.

Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A . Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013; 495(7441):333-8. DOI: 10.1038/nature11928. View

11.

Qu S, Yang X, Li X, Wang J, Gao Y, Shang R . Circular RNA: A new star of noncoding RNAs. Cancer Lett. 2015; 365(2):141-8. DOI: 10.1016/j.canlet.2015.06.003. View

12.

Sang M, Meng L, Sang Y, Liu S, Ding P, Ju Y . Circular RNA ciRS-7 accelerates ESCC progression through acting as a miR-876-5p sponge to enhance MAGE-A family expression. Cancer Lett. 2018; 426:37-46. DOI: 10.1016/j.canlet.2018.03.049. View

13.

Zhang X, Yang D, Wei Y . Overexpressed CDR1as functions as an oncogene to promote the tumor progression via miR-7 in non-small-cell lung cancer. Onco Targets Ther. 2018; 11:3979-3987. PMC: 6044366. DOI: 10.2147/OTT.S158316. View

14.

Dai X, Chen C, Yang Q, Xue J, Chen X, Sun B . Exosomal circRNA_100284 from arsenite-transformed cells, via microRNA-217 regulation of EZH2, is involved in the malignant transformation of human hepatic cells by accelerating the cell cycle and promoting cell proliferation. Cell Death Dis. 2018; 9(5):454. PMC: 5908808. DOI: 10.1038/s41419-018-0485-1. View

15.

Zhang J, Liu H, Hou L, Wang G, Zhang R, Huang Y . Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression. Mol Cancer. 2017; 16(1):151. PMC: 5594516. DOI: 10.1186/s12943-017-0719-3. View

16.

Bookman M, Brady M, McGuire W, Harper P, Alberts D, Friedlander M . Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup. J Clin Oncol. 2009; 27(9):1419-25. PMC: 2668552. DOI: 10.1200/JCO.2008.19.1684. View

17.

Tang W, Ji M, He G, Yang L, Niu Z, Jian M . Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7. Onco Targets Ther. 2017; 10:2045-2056. PMC: 5391170. DOI: 10.2147/OTT.S131597. View

18.

Li P, Yang X, Yuan W, Yang C, Zhang X, Han J . CircRNA-Cdr1as Exerts Anti-Oncogenic Functions in Bladder Cancer by Sponging MicroRNA-135a. Cell Physiol Biochem. 2018; 46(4):1606-1616. DOI: 10.1159/000489208. View

19.

Gao D, Qi X, Zhang X, Fang K, Guo Z, Li L . hsa_circRNA_0006528 as a competing endogenous RNA promotes human breast cancer progression by sponging miR-7-5p and activating the MAPK/ERK signaling pathway. Mol Carcinog. 2018; 58(4):554-564. DOI: 10.1002/mc.22950. View

20.

Xu L, Zhang M, Zheng X, Yi P, Lan C, Xu M . The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2016; 143(1):17-27. DOI: 10.1007/s00432-016-2256-7. View